Development of Environmentally Responsive Self-Emulsifying System Containing Copaiba Oil-Resin for Leishmaniasis Oral Treatment
暂无分享,去创建一个
C. Nakamura | M. Bruschi | W. Caetano | R. S. Gonçalves | Mônica Villa Nova | D. L. Bidóia | R. B. Balbinot | Mariana Carla de Oliveira
[1] C. Nakamura,et al. HPLC analysis of β-caryophyllene in copaiba oleoresin: Development, validation and applicability , 2022, Research, Society and Development.
[2] M. Bruschi,et al. Self-Emulsifying Systems for Delivery of Bioactive Compounds from Natural Origin , 2022, AAPS PharmSciTech.
[3] A. Bernkop‐Schnürch,et al. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface. , 2020, Nanomedicine.
[4] F. Pavan,et al. Acid diterpenes from Copaiba oleoresin (Copaifera langsdorffii): Chemical and plasma stability and intestinal permeability using Caco-2 cells. , 2019, Journal of ethnopharmacology.
[5] A. Bernkop‐Schnürch,et al. SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. , 2019, Advanced drug delivery reviews.
[6] U. Gupta,et al. Self-Emulsifying Oral Lipid Drug Delivery Systems: Advances and Challenges , 2019, AAPS PharmSciTech.
[7] I. Tho,et al. Micellisation Mechanism and Behaviour of Soluplus®–Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based System , 2019, Pharmaceuticals.
[8] Ana Figueiras,et al. β-caryophyllene Delivery Systems: Enhancing the Oral Pharmacokinetic and Stability. , 2018, Current pharmaceutical design.
[9] Stephan Sanders,et al. Pharmacopoeia , 2018, Oxford Handbook for the Foundation Programme.
[10] J. Váradi,et al. Physico-chemical characterization of self-emulsifying drug delivery systems. , 2018, Drug discovery today. Technologies.
[11] Marla Monyelly Silva Rabelo,et al. LEISHMANIOSE TEGUMENTAR AMERICANA , 2018 .
[12] R. López-Vélez,et al. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge , 2017, PLoS neglected tropical diseases.
[13] S. Percário,et al. Brazilian Amazon Traditional Medicine and the Treatment of Difficult to Heal Leishmaniasis Wounds with Copaifera , 2017, Evidence-based complementary and alternative medicine : eCAM.
[14] Sourav Bhattacharjee,et al. DLS and zeta potential - What they are and what they are not? , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[15] C. Martins,et al. Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens. , 2016, Anaerobe.
[16] Ranjita Shegokar,et al. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications , 2016, Expert opinion on drug delivery.
[17] Michael E. Aulton and Kevin M.G. Taylor.,et al. Aulton's pharmaceutics : , 2015 .
[18] Ines Kevric,et al. New World and Old World Leishmania Infections: A Practical Review. , 2015, Dermatologic clinics.
[19] Vikram Singh,et al. Self emulsifying systems: A review , 2015 .
[20] S. Sundar,et al. An update on pharmacotherapy for leishmaniasis , 2015, Expert opinion on pharmacotherapy.
[21] F. Supek,et al. Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis , 2014, Chemical reviews.
[22] J. Beijnen,et al. Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure. , 2014, The Journal of infectious diseases.
[23] S. Arora,et al. Lipid-Based Drug Delivery Systems , 2014, Journal of pharmaceutics.
[24] H. Syed,et al. Identification of phases of various oil, surfactant/ co-surfactants and water system by ternary phase diagram. , 2014, Acta poloniae pharmaceutica.
[25] Sandeep Kalepu,et al. Oral lipid-based drug delivery systems – an overview , 2013 .
[26] G. Fan,et al. Physicochemical characterization and pharmacokinetics evaluation of β-caryophyllene/β-cyclodextrin inclusion complex. , 2013, International journal of pharmaceutics.
[27] C. Nakamura,et al. Antileishmanial activity of diterpene acids in copaiba oil , 2013, Memorias do Instituto Oswaldo Cruz.
[28] Â. Pinto,et al. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. , 2012, Journal of medicinal chemistry.
[29] E. Lemichez,et al. Luciferase-Expressing Leishmania infantum Allows the Monitoring of Amastigote Population Size, In Vivo, Ex Vivo and In Vitro , 2011, PLoS neglected tropical diseases.
[30] C. Nakamura,et al. Copaiba Oil: An Alternative to Development of New Drugs against Leishmaniasis , 2011, Evidence-based complementary and alternative medicine : eCAM.
[31] P. Puranik,et al. Carbopol Polymers: A Versatile Polymer for Pharmaceutical Applications , 2010 .
[32] P. Zhang,et al. Intestinal permeability of sesquiterpenes in the caco-2 cell monolayer model. , 2010, Planta medica.
[33] L. Monzote. Current Treatment of Leishmaniasis: A Review , 2009 .
[34] Â. Pinto,et al. Effect of Brazilian copaiba oils on Leishmania amazonensis. , 2008, Journal of ethnopharmacology.
[35] P. Bates. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies , 2007, International journal for parasitology.
[36] Â. Pinto,et al. Chemical composition and anti-inflammatory activity of copaiba oils from Copaifera cearensis Huber ex Ducke, Copaifera reticulata Ducke and Copaifera multijuga Hayne--a comparative study. , 2007, Journal of ethnopharmacology.
[37] J. Barbosa-Filho,et al. Review of the plants with anti-inflammatory activity studied in Brazil , 2005 .
[38] Célia Maria Ferreira Gontijo,et al. Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas , 2004 .
[39] S. Benita,et al. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[40] A. C. Pinto,et al. O gênero copaifera L. , 2002 .
[41] M. Brandão,et al. Biological screening of Brazilian medicinal plants. , 2000, Memorias do Instituto Oswaldo Cruz.
[42] O. Antunes,et al. Terpenoids from Copaiba Cearensis , 1998 .
[43] T. Meshulam,et al. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). , 1995, The Journal of infectious diseases.
[44] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[45] A. Brito,et al. Forty years of Brazilian medicinal plant research. , 1993, Journal of ethnopharmacology.
[46] Alexander T. Florence,et al. Physicochemical Principles of Pharmacy , 1988 .
[47] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[48] P. S. Santos,et al. Pharmaceutical potentialities of β-caryophyllene for drug delivery systems: a prospection , 1969 .
[49] V. Pandey,et al. Lipids and Surfactants: The Inside Story of Lipid-Based Drug Delivery Systems. , 2018, Critical reviews in therapeutic drug carrier systems.
[50] Huimin Wu,et al. Novel self-assembled tacrolimus nanoparticles cross-linking thermosensitive hydrogels for local rheumatoid arthritis therapy. , 2017, Colloids and surfaces. B, Biointerfaces.
[51] L. Casettari,et al. Rheological characterization of polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer (Soluplus®) water dispersions , 2013, Colloid and Polymer Science.
[52] Me Aulton,et al. Aulton's pharmaceutics: the design and manufacture of medicines , 2007 .
[53] Patrick J. Sinko,et al. Martin's physical pharmacy and pharmaceutical sciences : physical chemical and biopharmaceutical principles in the pharmaceutical sciences , 2006 .
[54] C J Marinkelle,et al. The control of leishmaniases. , 1980, Bulletin of the World Health Organization.